Dr. Kannan Sridharan is a distinguished Professor of Pharmacology and Therapeutics at the Arabian Gulf University, Manama, Bahrain, with a prolific research career spanning clinical pharmacology, pharmacogenomics, and evidence-based medicine. Holding an MBBS, MD (Pharmacology), and a Ph.D.-equivalent DM (Clinical Pharmacology), Dr. Sridharan has authored over 200 publications in high-impact journals, including Nature Reviews Disease Primers and Journal of Hepatology, with several papers featuring impact factors exceeding 70. His work has consistently ranked him among the world’s top 2% cited scientists (2019–2023). The areas of research focus include drugs safety and pharmacovigilance, pharmacogenomics, evidence-based medicine, and neonatal pharmacology.